TREVISAN, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 3.825
EU - Europa 1.913
AS - Asia 820
SA - Sud America 13
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 6.585
Nazione #
US - Stati Uniti d'America 3.774
IE - Irlanda 487
IT - Italia 437
HK - Hong Kong 356
SE - Svezia 329
DE - Germania 288
CN - Cina 165
SG - Singapore 154
RU - Federazione Russa 118
GB - Regno Unito 77
CA - Canada 50
IN - India 41
UA - Ucraina 40
VN - Vietnam 28
ID - Indonesia 27
DK - Danimarca 26
BE - Belgio 20
FI - Finlandia 20
NL - Olanda 16
CZ - Repubblica Ceca 12
TR - Turchia 10
BR - Brasile 9
FR - Francia 7
PL - Polonia 7
ES - Italia 6
IR - Iran 6
PH - Filippine 6
AU - Australia 5
KR - Corea 5
SA - Arabia Saudita 5
HR - Croazia 4
JP - Giappone 4
NO - Norvegia 4
EG - Egitto 3
EU - Europa 3
GR - Grecia 3
MY - Malesia 3
RS - Serbia 3
TH - Thailandia 3
BG - Bulgaria 2
EE - Estonia 2
IL - Israele 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PE - Perù 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
MN - Mongolia 1
NP - Nepal 1
RO - Romania 1
Totale 6.585
Città #
Ann Arbor 669
Dublin 474
Chandler 403
Fairfield 387
Hong Kong 355
Ashburn 269
Frankfurt am Main 248
New York 238
Princeton 223
Houston 179
Woodbridge 175
Wilmington 168
Seattle 148
Cambridge 119
Lawrence 107
Singapore 105
Altamura 99
Milan 77
San Diego 44
Shanghai 41
Toronto 40
Jacksonville 37
Beijing 28
Jakarta 27
Andover 24
London 22
Brussels 19
Dearborn 19
Boardman 18
Nanjing 18
Rome 18
Chicago 15
Falls Church 13
Guangzhou 12
Helsinki 11
Bergamo 10
Brno 10
Los Angeles 10
Pune 10
Washington 10
Fuzhou 9
Dong Ket 8
Florence 8
Hangzhou 8
Norwalk 7
Redmond 7
Shenzhen 7
São Paulo 7
Groningen 6
Kilburn 6
San Mateo 6
Villafranca Padovana 6
Bologna 5
Brescia 5
Lappeenranta 5
Mumbai 5
Riyadh 5
Wuhan 5
Belvedere Spinello 4
Chennai 4
Deyang 4
Fremont 4
Hebei 4
Islington 4
Lachine 4
Munich 4
Perugia 4
Poznan 4
Turin 4
Verano Brianza 4
Zagreb 4
Bangalore 3
Bari 3
Bivongi 3
Cairo 3
Capurso 3
Cernusco Sul Naviglio 3
Changsha 3
Chengdu 3
Dongjak-gu 3
Edmonton 3
Esslingen am Neckar 3
Ferrara 3
Glasgow 3
Gunzenhausen 3
Hounslow 3
Jalandhar 3
Jinan 3
Kocaeli 3
Leicester 3
Montello 3
Naples 3
Oslo 3
Patna 3
Santa Clara 3
Stockholm 3
Tianjin 3
Upper Marlboro 3
Alicante 2
Atlanta 2
Totale 5.151
Nome #
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched Italian multicenter study. 239
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 217
Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus: The Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) Randomized Clinical Trial 170
Effects of a low glycemic index high in fiber diet on blood glucose in women with gestational diabetes 144
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 138
Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study 136
Switching from Suspend-Before-Low Insulin Pump Technology to a Hybrid Closed-Loop System Improves Glucose Control and Reduces Glucose Variability: A Retrospective Observational Case-Control Study 123
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 114
Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes—The TOSCA.IT Study 107
Pre-gestational diabetes during the COVID-19 pandemic in Bergamo, Italy 107
Genitourinary infections in diabetic patients in the new era of diabetes therapy with sodium-glucose cotransporter-2 inhibitors 107
Association between On-Treatment Haemoglobin A1c and All-Cause Mortality in Individuals with Type 2 Diabetes: Importance of Personalized Goals and Type of Anti-Hyperglycaemic Treatment 106
Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies 102
Subcutaneous insulin infusion (CSII) in italy: The third national survey [La terapia insulinica sottocutanea continua (CSII) in Italia. Terza indagine nazionale] 99
Continuous subcutaneous insulin infusion in Italy: Third national survey 98
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients 96
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial 91
Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes 90
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 90
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 88
Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study 84
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial 81
Association between inhibitors of the renin-angiotensin system and lung function in elderly patients recovered from severe COVID-19 81
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 79
Sodium-glucose transporter 2 inhibitors for renal and cardiovascular protection in US adults with type 2 diabetes: impact of the 2020 KDIGO clinical practice guidelines 78
Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: Findings from an administrative database 76
Gestione multidisciplinare del paziente con sindrome coronarica acuta e diabete mellito: Dalla terapia antitrombotica al trattamento dell'iperglicemia 75
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus 75
La malattia renale e le sue complicanze: percorso per una diagnosi precoce e gestione multidisciplinare 74
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study 74
Blood pressure and metabolic effects of acetyl-L-carnitine in type 2 diabetes: DIABASI randomized controlled trial 70
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study 69
Preventing microalbuminuria with benazepril, valsartan, and benazepril-valsartan combination therapy in diabetic patients with high-normal albuminuria: A prospective, randomized, open-label, blinded endpoint (PROBE) study 69
Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 68
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial 68
Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy 65
Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study 65
Reply to "Liver fibrosis assessed by transient elastography and albuminuria" 65
Hypertriglyceridemia Is Independently Associated with Renal, but Not Retinal Complications in Subjects with Type 2 Diabetes: A Cross-Sectional Analysis of the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 64
Glycated haemoglobin does not accurately predict average capillary glucose in non insulin-treated type 2 diabetes: The PRISMA study experience 59
The Hyperfiltering Kidney in Diabetes 59
"Insulin autoimmune syndrome": Two very different cases [“Insulin autoimmune syndrome”: Due casi molto diversi] 58
Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation 57
Independent correlates of urinary albumin excretion within the normoalbuminuric range in patients with type 2 diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 57
Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease 57
Efficacy of self-monitoring blood glucose as a key component of a chronic care model versus usual care in type 2 diabetes patients treated with oral agents: results of a randomized trial 52
The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction 51
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 51
Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: A multicenter case-control retrospective observational study 50
Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial 49
Impact of a complement factor H gene variant on renal dysfunction, cardiovascular events and response to ACE inhibitor therapy in type 2 diabetes 49
Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group 49
Atrial natriuretic factor in hypertensive and normotensive insulin-dependent diabetics 48
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial 48
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial 48
Lipids and renal disease 47
Effect of insulin and angiotensin II on cell calcium in human skin fibroblasts 47
Ronal and metabolic effects of insulin lispro in type 2 diabetic sublects with overt nephropathy 46
Diabetes and work: The need of a close collaboration between diabetologist and occupational physician 45
Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial 45
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial 44
COMBINED "EN BLOC" LIVER-PANCREAS TRANSPLANTATION USING WHOLE SIZE AND SPLIT LIVER GRAFTS 44
Modulatory effect of insulin on release of calcium from human fibroblasts by angiotensin II 44
Sodium-hydrogen antiporter: Its possible role in the genesis of diabetic nephropathy 43
Diabetes mellitus in critical jobs [Diabete mellito in attività lavorative critiche] 43
In situ Protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 42
Treatment of diabetes in patients with kidney disease 42
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial 42
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes 42
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria 42
Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes 41
Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012 40
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial 40
PC-1 amino acid variant Q121 is associated with a lower glomerular filtration rate in type 2 diabetic patients with abnormal albumin excretion rates 40
Increased prevalence of autoimmune thyroid disease after COVID-19: A single-center, prospective study 39
The decorin gene 179 allelic variant is associated with a slower progression of renal disease in patients with type 1 diabetes 39
A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria 38
Dapagliflozin and cardiovascular outcomes in type 2 diabetes 38
Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System 38
Liver Stiffness, Albuminuria and Chronic Kidney Disease in Patients with NAFLD: A Systematic Review and Meta-Analysis 37
Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration 36
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes 36
Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta-analysis from the GetGoal programme 35
Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control 35
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial 35
Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes 34
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus 32
Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population 31
Resistant hypertension in patients with type 2 diabetes: clinical correlates and association with complications 30
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 29
The effect of Mindfulness therapy in acromegaly, a pilot study 28
Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity 28
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes 27
Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy 26
Preventing microalbuminuria in type 2 diabetes 26
Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis 26
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial) 26
The Remission Clinic approach to halt the progression of kidney disease 26
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin 25
Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control 25
Totale 6.328
Categoria #
all - tutte 41.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020415 25 15 8 10 16 21 21 95 98 51 35 20
2020/20211.525 176 174 157 119 74 85 150 123 110 154 94 109
2021/20221.202 99 85 90 67 23 42 60 58 41 256 73 308
2022/20231.926 217 589 154 104 165 327 5 84 114 45 64 58
2023/20241.789 53 48 63 68 264 416 302 61 252 43 22 197
2024/2025159 159 0 0 0 0 0 0 0 0 0 0 0
Totale 7.177